Bespoke Extracts (BSPK) Change in Receivables (2018 - 2025)
Bespoke Extracts (BSPK) reported Change in Receivables of $2525.0 for Q3 2025, up 119.27% on a YoY basis from $1151.5 in Q3 2024, and down 96.07% sequentially from $64250.0 in Q2 2025.
Bespoke Extracts (BSPK) Change in Receivables (2018 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 8 years of Change in Receivables data on file, last reported at $2525.0 in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables rose 119.27% year-over-year to $2525.0; the trailing twelve-month figure through Sep 2025 stood at $57449.0 (up 43094.74% YoY), and the FY2024 full-year result was $12050.0, down 73.36% from the prior year.
- Change in Receivables slipped to $2525.0 in Q3 2025, from $64250.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $64250.0 in Q2 2025 to a low of -$36627.0 in Q2 2023.
- A 5-year average of $6213.5 and a median of $293.0 in 2021 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 72529.69% in 2023, while the deepest fall reached 16398.65% in 2023.
- Tracing BSPK's Change in Receivables over 5 years: stood at -$588.0 in 2021, then soared by 62.24% to -$222.0 in 2022, then tumbled by 226.13% to -$724.0 in 2023, then surged by 1645.99% to $11193.0 in 2024, then tumbled by 77.44% to $2525.0 in 2025.
- Business Quant data shows BSPK's Change in Receivables at $2525.0 in Q3 2025, $64250.0 in Q2 2025, and -$20519.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 2,525.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,525.00 |
| Sep 30, 2025 | 2,525.00 |
| Jun 30, 2025 | 64,250.00 |
| Jun 30, 2025 | 64,250.00 |
| Mar 31, 2025 | -20,519.00 |
| Mar 31, 2025 | -20,519.00 |
| Dec 31, 2024 | 11,193.00 |
| Dec 31, 2024 | 11,193.00 |
| Sep 30, 2024 | -13,102.00 |
| Sep 30, 2024 | -13,102.00 |
| Jun 30, 2024 | 16,060.00 |
| Jun 30, 2024 | 16,060.00 |
| Mar 31, 2024 | -2,101.00 |
| Mar 31, 2024 | -2,101.00 |
| Dec 31, 2023 | -724.00 |
| Dec 31, 2023 | -724.00 |
| Sep 30, 2023 | 36,094.00 |
| Sep 30, 2023 | 36,094.00 |
| Jun 30, 2023 | -36,627.00 |
| Jun 30, 2023 | -36,627.00 |